SMARCB1 (INI1)-negative rhabdoid carcinomas of the gastrointestinal tract: Clinicopathologic and molecular study of a highly aggressive variant with literature review

American Journal of Surgical Pathology

Volumn 38, Issue 7, 2014, Pages 910-920

  Agaimy, Abbas ^a   Rau, Tilman T ^a   Hartmann, Arndt ^a   Stoehr, Robert ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

CIMP; dedifferentiation; gastrointestinal; promoter methylator phenotype; rhabdoid carcinoma; rhabdoid phenotype; SMARCB1 INI1

Indexed keywords

DNA BINDING PROTEIN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CASE REPORT; CELL DIFFERENTIATION; CHEMISTRY; FATALITY; GASTROINTESTINAL TUMOR; GENETICS; GENOTYPE; HUMAN; MALE; PATHOLOGY; PHENOTYPE; RHABDOID TUMOR; TIME; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; CELL DIFFERENTIATION; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; FATAL OUTCOME; GASTROINTESTINAL NEOPLASMS; GENOTYPE; HUMANS; MALE; PHENOTYPE; RHABDOID TUMOR; TIME FACTORS; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84902545170     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0000000000000173     Document Type: Article

References (58)

1. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer. 1978;41: 1937-1948.
2. Weeks DA, Beckwith JB, Mierau GW, et al. Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. Am J Surg Pathol. 1989;13: 439-458.
3. Parham DM, Weeks DA, Beckwith JB. The clinicopathologic spectrum of putative extrarenal rhabdoid tumors. An analysis of 42 cases studied with immunohistochemistry or electron microscopy. Am J Surg Pathol. 1994;18: 1010-1029.
4. Fanburg-Smith JC, Hengge M, Hengge UR, et al. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases. Ann Diagn Pathol. 1998;2: 351-362.
5. Biegel JA, Tan L, Zhang F, et al. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Clin Cancer Res. 2002;8: 3461-3467.
6. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol. 2011;35: e47-e63.
7. Wick MR, Ritter JH, Dehner LP. Malignant rhabdoid tumors: a clinicopathologic review and conceptual discussion. Semin Diagn Pathol. 1995;12: 233-248.
8. Sommers SC, Meissner WA. Unusual carcinomas of the pancreas. Arch Path. 1954;58: 101-111.
9. Nash AD, Stout AP. Giant cell carcinoma of the lung: report of five cases. Cancer. 1958;11: 369-376.
10. Guillan RA. Pleomorphic adenocarcinoma of the pancreas. An analysis of five cases. Cancer. 1968;21: 1072-1079.
11. Guo KJ, Yamaguchi K, Enjoji M. Undifferentiated carcinoma of the gallbladder. A clinicopathologic, histochemical, and immunohistochemical study of 21 patients with a poor prognosis. Cancer. 1988;61: 1872-1879.
12. Bak M, Teglbjaerg PS. Pleomorphic (giant cell) carcinoma of the intestine. An immunohistochemical and electron microscopic study. Cancer. 1989;64: 2557-2564.
13. Jones EA, Flejou JF, Molas G, et al. Pleomorphic carcinoma of the small bowel. The limitations of immunohistochemical specificity. Pathol Res Pract. 1991;187: 235-240.
14. Ueyama T, Nagai E, Yao T, et al. Vimentin-positive gastric carcinomas with rhabdoid features. A clinicopathologic and immunohistochemical study. Am J Surg Pathol. 1993;17: 813-819.
15. Chetty R, Bhathal PS. Caecal adenocarcinoma with rhabdoid phenotype: an immunohistochemical and ultrastructural analysis. Virchows Arch A Pathol Anat Histopathol. 1993;422: 179-182.
16. Yang AH, Chen WY, Chiang H. Malignant rhabdoid tumour of colon. Histopathology. 1994;24: 89-91.
17. Macák J, Kodet R. Rectal adenocarcinoma with rhabdoid phenotype. Pathologica. 1995;87: 696-699.
18. Marcus VA, Viloria J, Owen D, et al. Malignant rhabdoid tumor of the colon. Report of a case with molecular analysis. Dis Colon Rectum. 1996;39: 1322-1326.
19. Read HS, Webb JN, Macintyre IM. Malignant rhabdoid tumour of stomach. Histopathology. 1996;29: 474-477.
20. Leong FJ, Leong AS. Malignant rhabdoid tumor in adults- heterogenous tumors with a unique morphological phenotype. Pathol Res Pract. 1996;192: 796-807.
21. Pinto JA, González Alfonso JE, González L, et al. Well differentiated gastric adenocarcinoma with rhabdoid areas: a case report with immunohistochemical analysis. Pathol Res Pract. 1997;193: 801-805.
22. Lee JR, Chamberlain CR, Gerrity RG, et al. Malignant rhabdoid tumor of the duodenum. Ann Diagn Pathol. 1998;2: 25-30.
23. Chen Y, Jung SM, Chao TC. Malignant rhabdoid tumor of the small intestine in an adult: a case report with immunohistochemical and ultrastructural findings. Dig Dis Sci. 1998;43: 975-979.
24. Al-Nafussi A, O'Donnell M. Poorly differentiated adenocarcinoma with extensive rhabdoid differentiation: clinicopathological features of two cases arising in the gastrointestinal tract. Pathol Int. 1999;49: 160-163.
25. Nakamura I, Nakano K, Nakayama K, et al. Malignant rhabdoid tumor of the colon: report of a case. Surg Today. 1999;29: 1083-1087.
26. Rivera-Hueto F, Ríos-Martín JJ, Domínguez-Triano R, et al. Early gastric stump carcinoma with rhabdoid features. Case report. Pathol Res Pract. 1999;195: 841-846.
27. Amrikachi M, Ro JY, Ordonez NG, et al. Adenocarcinomas of the gastrointestinal tract with prominent rhabdoid features. Ann Diagn Pathol. 2002;6: 357-363.
28. Ng WC, Leong HT, Ma KF, et al. Malignant rhabdoid tumour of the oesophagus: a case report. J Clin Pathol. 2003;56: 713-714.
29. Varghese LR, Stanley MW, Lucido ML, et al. Esophageal carcinoma with a rhabdoid phenotype: a case report of diagnosis by endoscopic ultrasound-guided fine-needle aspiration. Diagn Cytopathol. 2005;33: 407-411.
30. Kunze E, Heidrich G, Brück W, et al. Malignant rhabdoid tumours of the jejunum, chest wall and adrenal glands. Histopathology. 2007;50: 659-663.
31. Kono T, Imai Y, Imura J, et al. Cecal adenocarcinoma with prominent rhabdoid feature: report of a case with immunohistochemical, ultrastructural, and molecular analyses. Int J Surg Pathol. 2007;15: 414-420.
32. Sheikh SS, Al-Khatti AA, Amr SS. Metachronous malignant rhabdoid tumor of the ileum and adenocarcinoma of lung: a unique case report. Ann Diagn Pathol. 2008;12: 57-61.
33. Salamanca J, Nevado M, Martínez-González MA, et al. Undifferentiated carcinoma of the jejunum with extensive rhabdoid features. Case report and review of the literature. APMIS. 2008; 116: 941-946.
34. Tóth L, Nemes Z, Gomba S, et al. Primary rhabdoid cancer of the ileum: a case report and review of the literature. Pathol Res Pract. 2010;206: 110-115.
35. Sharma S, Gupta R, Sharma R, et al. Mucin-secreting gastric adenocarcinoma with Rhabdoid areas. Saudi J Gastroenterol. 2010;16: 46-48.
36. Geramizadeh B, Nikeghbalian S, Abolghasem-Hosseini S. Primary malignant rhabdoid tumor of the stomach, a rare case report and review of literature. J Gastrointest Cancer. 2010;41: 269-271.
37. Pancione M, Di Blasi A, Sabatino L, et al. A novel case of rhabdoid colon carcinoma associated with a positive CpG island methylator phenotype and BRAF mutation. Hum Pathol. 2011; 42: 1047-1052.
38. Shomori K, Sugamura K, Adachi K, et al. Gastric adenocarcinoma with rhabdoid morphology. Gastric Cancer. 2011;14: 290-294.
39. Remo A, Zanella C, Molinari E, et al. Rhabdoid carcinoma of the colon: a distinct entity with a very aggressive behavior: a case report associated with a polyposis coli and review of the literature. Int J Surg Pathol. 2012;20: 185-190.
40. Nardon E, Glavac D, Benhattar J, et al. A multicenter study to validate the reproducibility of MSI testing with a panel of 5 quasimonomorphic mononucleotide repeats. Diagn Mol Pathol. 2010;19: 236-242.
41. Utsunomiya T, Yao T, Masuda K, et al. Vimentin-positive adenocarcinomas of the stomach: co-expression of vimentin and cytokeratin. Histopathology. 1996;29: 507-516.
42. Pancione M, Remo A, Sabatino L, et al. Right-sided rhabdoid colorectal tumorsmight be related to the serrated pathway. Diagn Pathol. 2013;20:31.
43. Miyagi J, Tsuhako K, Kinjo T, et al. Rhabdoid tumour of the lung is a dedifferentiated phenotype of pulmonary adenocarcinoma. Histopathology. 2000;37: 37-44.
44. Bittesini L, Dei Tos AP, Fletcher CD. Metastatic malignant melanoma showing a rhabdoid phenotype: further evidence of a non-specific histological pattern. Histopathology. 1992;20: 167-170.
45. Perry A, Fuller CE, Judkins AR, et al. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Mod Pathol. 2005;18: 951-958.
46. Cho YM, Choi J, Lee OJ, et al. SMARCB1/INI1 missense mutation in mucinous carcinoma with rhabdoid features. Pathol Int. 2006; 56: 702-706.
47. Donner LR, Wainwright LM, Zhang F, et al. Mutation of the INI1 gene in composite rhabdoid tumor of the endometrium. Hum Pathol. 2007;38: 935-939.
48. Kleinschmidt-DeMasters BK, Birks DK, Aisner DL, et al. Atypical teratoid/rhabdoid tumor arising in a ganglioglioma: genetic characterization. Am J Surg Pathol. 2011;35: 1894-1901.
49. Guillou L, Wadden C, Coindre JM, et al. "Proximal-type" epithelioid sarcoma, a distinctive aggressive neoplasm showing rhabdoid features. Clinicopathologic, immunohistochemical, and ultrastructural study of a series. Am J Surg Pathol. 1997;21: 130-146.
50. Hornick JL, Dal Cin P, Fletcher CD. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009;33: 542-550.
51. Sullivan LM, Folpe AL, Pawel BR, et al. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol. 2013;26: 385-392.
52. Tsai CY, Wong TT, Lee YH, et al. Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity. Am J Surg Pathol. 2012;36: 128-133.
53. Maggiani F, Debiec-Rychter M, Ectors N, et al. Primary epithelioid sarcoma of the oesophagus. Virchows Arch. 2007;451: 835-838.
54. Venizelos I, Anagnostou E, Papathomas TG, et al. Proximal-type epithelioid sarcoma of the uterine corpus. Histopathology. 2011; 58: 321-323.
55. Otera H, Ikeda F, Nakagawa S, et al. Intussusception of small intestine due to metastasis of large cell carcinoma of the lung with a rhabdoid phenotype. Eur Respir Rev. 2010;19: 248-252.
56. Liu X, Cheng Y, Sheng W, et al. Analysis of clinicopathologic features and prognostic factors in hepatoid adenocarcinoma of the stomach. Am J Surg Pathol. 2010;34: 1465-1471.
57. Schaefer IM, Ströbel P, Cameron S, et al. Rhabdoid morphology in gastrointestinal stromal tumours (GISTs) is associated with PDGFRA mutations but does not imply an aggressive behaviour. Histopathology. 2014;64: 421-430.
58. Hanson JA, Trent JC, Yang D, et al. Small-intestinal rhabdoid gastrointestinal stromal tumor (GIST): mutation analysis and clinical implications of a rare morphological variant. Int J Surg Pathol. 2011;19: 653-657.